Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy

Biochemical Society Transactions

Volumn 31, Issue 2, 2003, Pages 397-406

  Blagbrough, I S ^a   Geall, A J ^a   Neal, A P ^a  

^a University of Bath   (United Kingdom)

Author keywords

Bile acid; Cholesterol; Gene therapy; Hydroboration; Spermidine; Spermine; Steroid

Indexed keywords

PUTRESCINE; SPERMIDINE; SPERMINE;

ANALYTIC METHOD; B LYMPHOCYTE ACTIVATION; CHROMATIN CONDENSATION; CONFERENCE PAPER; CONJUGATE; COVALENT BOND; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; MOLECULAR PROBE; NONVIRAL GENE THERAPY; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RESPIRATORY CHAIN; STRUCTURE ACTIVITY RELATION;

DNA; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FLUORESCENT DYES; GENE THERAPY; HUMANS; POLYAMINES;

EID: 0037398046     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0310397     Document Type: Conference Paper

References (93)

1. Onodera, M. and Sakiyama, Y. (2000) Expert Opin. Invest. Drugs 9, 543-549
2. Otsu, M. and Candotti, F. (2002) Biodrugs 16, 229-239
3. Buckley, R.H. (2002) Lancet 360, 1185-1186
4. Barnes, M.N. and Pustilnik, T.B. (2001) Curr. Opin. Obstet. Gynecol. 13, 47-51
5. Xu, L., Pirollo, K.F. and Chang, E.H. (2001) J. Cont. Rel. 74, 115-128
6. Bettinger, T. and Read, M.L. (2001) Curr. Opin. Mol. Therapeut. 3, 116-124
7. Davies, J.C., Geddes, D.M. and Alton, E.W.F.W. (2001) J. Gene Med. 3, 409-417
8. Chuah, M.K.L., Collen, D. and van den Driessche, T. (2001) J. Gene Med. 3, 3-20
9. Chiou, H.C., Lucas, M.A., Coffin, C.C., Banaszczyk, M.G., Ill, C.R. and Lollo, C.P. (2001) Expert Opin. Biol. Therapy 1, 629-639
10. Weissig, V. and Torchilin, V.P. (2001) Adv. Drug Del. Rev. 49, 127-149
11. Silman, N.J. and Fooks, A.R. (2000) Curr. Opin. Mol. Therapeut. 2, 524-531
12. Chang, L.J. and He, J. (2001) Curr. Opin. Mol. Therapeut. 3, 468-475
13. Mergia, A., Chari, S., Kolson, D.L., Goodenow, M.M. and Ciccarone, T. (2001) Virology 280, 243-252
14. Blagbrough, I.S., Carrington, S. and Geall, A.J. (1997) Pharm. Sci. 3, 223-233
15. Prince, H.M. (1998) Pathology 30, 335-347
16. Schatzlein, A.G. (2001) Anti-Cancer Drugs 12, 275-304
17. Brown, M.D., Schatzlein, A.G. and Uchegbu, I.F. (2001) Int. J. Pharm. 229, 1-21
18. Pouton, C.W. and Seymour, L.W. (2001) Adv. Drug Del. Rev. 46, 187-203
19. Lee, H., Williams, S.K.R., Allison, S.D. and Anchordoquy, T.J. (2001) Anal. Chem. 73, 837-843
20. Walker, S., Sofia, M.J., Kakarla, R., Kogan, N.A., Wierichs, L., Longley, C.B., Bruker, K., Axelrod, H.R., Midha, S., Babu, S. and Kahne, D. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 1585-1590
21. Lee, E.R., Marshall, J., Siegel, C.S., Jiang, C.W., Yew, N.S., Nichols, M.R., Nietupski, J.B., Ziegler, R.J., Lane, M.B., Wang, K.X. et al. (1996) Hum. Gene Therapy 7, 1701-1717
22. Kwok, K.Y., Yang, Y.S. and Rice, K.G. (2001) Curr. Opin. Mol. Therapeut. 3, 142-146
23. Byk, G., Wetzer, B., Frederic, M., Dubertret, C., Pitard, B, Jaslin, G. and Scherman, D. (2000) J. Med. Chem. 43, 4377-4387
24. Wetzer, B., Byk, G., Frederic, M., Airiau, M., Blanche, F., Pitard, B. and Scherman, D. (2001) Biochem. J. 356, 747-756
25. Dauty, E., Remy, J.S., Blessing, T. and Behr, J.-P. (2001) J. Am. Chem. Soc. 123, 9227-9234
26. Ilies, M.A. and Bataban, A.T. (2001) Expert Opin. Therap. Pat. 11, 1729-1752
27. Pouton, C.W. (1998) Adv. Drug Del. Rev. 34, 51-64
28. Johnson-Saliba, M. and Jans, D.A. (2001) Curr. Drug Targets 2, 371-399
29. Cartier, R. and Reszka, R. (2002) Gene Therapy 9, 157-167
30. Remy, J.S., Sirlin, C., Vierling, P. and Behr, J.-P. (1994) Bioconj. Chem. 5, 647-654
31. Mahato, R.I., Rolland, A. and Tomlinson, E. (1997) Pharm. Res. 14, 853-859
32. Behr, J.-P., Demeneix, B., Loeffler, J.-P. and Perez-Mutul, J. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 6982-6986
33. Donohue, R., Mazzaglia, A., Ravoo, B.J. and Darcy, R. (2002) Chem. Commun. 2864-2865
34. Byk, G., Dubertret, C., Escriou, V., Frederic, M., Jaslin, G., Rangara, R., Pitard, B., Crouzet, J., Wils, P., Schwartz, B. and Scherman, D. (1998) J. Med. Chem. 41, 224-235
35. Ewert, K., Ahmad, A., Evans, H.M., Schmidt, H.-W. and Safinya, C.R. (2002) J. Med. Chem. 45, 5023-5029
36. Klosel, R. and Konig, S. (1999) PCT Int. Appl. WO 9908997, 1-64
37. Bruson, H.A. (1949) Org. React. 5, 79-135
38. Vigneron, J.P., Oudrhiri, N., Fauquet, M., Vergely, L., Bradley, J.C., Basseville, M., Lehn, P. and Lehn, J.-M. (1996) Proc. Natl. Acad. Sci U.S.A. 93, 9682-9686
39. Oudrhiri, N., Vigneron, J.P., Peuchmaur, M., Leclerc, T., Lehn, J.-M. and Lehn, P. (1997) Proc. Natl. Acad. Sci. U.S.A 94, 1651-1656
40. Pitard, B., Oudrhiri, N., Vigneron, J.P., Hauchecorne, M., Aguerre, O., Toury, R., Airiau, M., Ramasawmy, R., Scherman, D., Crouzet, J., Lehn, J.-M. and Lehn, P. (1999) Proc. Natl. Acad. Sci. U.S.A. 96, 2621-2626
41. Lehn, P., Fabrega, S., Oudrhiri, N. and Navarro, J. (1998) Adv. Drug Del. Rev. 30, 5-11
42. Aissaoui, A., Oudrhiri, N., Petit, L., Hauchecorne, M., Kan, E., Sainlos, M., Julia, S., Navarro, J., Vigneron, J.P., Lehn, J.-M. and Lehn, P. (2002) Curr. Drug Targets 3, 1-16
43. Ren, T., Zhang, G.S., Liu, F. and Liu, D.X. (2000) Bioorg. Med. Chem. Lett. 10, 891-894
44. Nakamura, E., Isobe, H., Tomita, N., Sawamura, M., Jinno, S. and Okayama, H. (2000) Angew. Chem. 39, 4254-4257
45. Camilleri, P., Kremer, A., Edwards, A.J., Jennings, K.H., Jenkins, O., Marshall, I., McGregor, C., Neville, W., Rice, S.Q., Smith, R.J. et al. (2000) Chem. Commun. 1253-1254 and 1553
46. McGregor, C., Perrin, C., Monck, M., Camilleri, P. and Kirby, A.J. (2001) J. Am. Chem. Soc. 123, 6215-6220
47. Ronsin, G., Perrin, C., Guedat, P., Kremer, A., Camilleri, P. and Kirby, A.J. (2001) Chem. Commun. 2234-2235
48. Neal, A.P. and Blagbrough, I.S. (2000) J. Pharm. Pharmacol. 52, 5116
49. Neal, A.P. and Blagbrough, I.S. (2001) Abs. Pap. Am. Chem. Soc. 221 332-MEDI, part 2
50. Neal, A.P. and Blagbrough, I.S. (2001) Abs. Pap. Am. Chem. Soc. 221 352-MEDI, part 2
51. Neal, A.P. and Blagbrough, I.S. (2001) J. Pharm. Pharmacol. 53, 51
52. Neal, A.P. and Blagbrough, I.S. (2001) J. Pharm. Pharmacol. 53, 5245
53. Neal, A.P. and Blagbrough, I.S. (2002) Abs. Pap. Am. Chem. Soc. 224, 161-MEDI, part 2
54. Blagbrough, I.S., Geall, A.J. and Neal, A.P. (2002) Abs. Pap. Am. Chem. Soc. 224, 215-MEDI, part 2
55. Blagbrough, I.S. and Geall, A.J. (2002) Abs. Pap. Am. Chem. Soc. 224, 195-MEDI, part 2
56. Geall, A.J., Taylor, R.J., Earll, M.E., Eaton, M.A.W. and Blagbrough, I.S. (1998) Chem. Commun. 1403-1404 and 1607
57. Geall, A.J., Al-Hadithi, D. and Blagbrough, I.S. (1998) Chem. Commun. 2035-2036
58. Blagbrough, I.S., Al-Hadithi, D. and Geall, A.J. (1999) Pharm. Pharmacol. Commun. 5, 139-144
59. Geall, A.J. and Blagbrough, I.S. (1999) Pharm. Pharmacol. Commun. 5, 145-150
60. Geall, A.J., Taylor, R.J., Earll, M.E., Eaton, M.A.W. and Blagbrough, I.S. (2000) Bioconj. Chem. 11, 314-326
61. Geall, A.J. and Blagbrough, I.S. (2000) Tetrahedron 56, 2449-2460
62. Blagbrough, I.S., Al-Hadithi, D. and Geall, A.J. (2000) Tetrahedron 56, 3439-3447
63. Geall, A.J., Al-Hadithi, D. and Blagbrough, I.S. (2002) Bioconj. Chem. 13, 481-490
64. Neves, C., Byk, G., Escriou, V., Bussone, F., Scherman, D. and Wils, P. (2000) Bioconj. Chem. 11, 51-55
65. Boussif, O., Lezoualch, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.-P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301
66. Godbey, W.T., Wu, K.K. and Mikos, A.G. (1999) Proc. Natl. Acad. Sci. U.S.A 96, 5177-5181
67. Tavares, R., Randoux, T., Braekman, J.-C. and Daloze, D. (1993) Tetrahedron 49, 5079-5090
68. Jung, M.E. and Johnson, T.W (2001) Tetrahedron 57, 1449-1481
69. Ueki, M. and Amemiya, M. (1987) Tetrahedron Lett. 28, 6617-6620
70. Geall, A.J. and Blagbrough, I.S. (2000) J. Pharm. Biomed. Anal. 22, 849-859
71. Geall, A.J., Eaton, M.A.W., Baker, T., Catterall, C. and Blagbrough, I.S. (1999) FEBS Lett. 459, 337-342
72. Kral, T., Hof, M., Jurkiewicz, P. and Langner, M. (2002) Cell. Mol. Biol. Lett. 7, 203-211
73. Kral, T., Hof, M. and Langner, M. (2002) Biol. Chem. 383, 331-335
74. Kral, T., Langner, M, Benes, M., Baczynska, D., Ugorski, M. and Hof, M. (2002) Biophys. Chem. 95, 135-144
75. Gold, B. (2002) Biopolymers 65, 173-179
76. Li, Z.J., Huang, L., Dande, P., Gold, B. and stone, M.P. (2002) J. Am. Chem. Soc. 124, 8553-8560
77. Haworth, I.S., Rodger, A. and Richards, W.G. (1991) Proc. R. Soc. London Ser. B 244, 107-116
78. Haworth, I.S., Rodger, A. and Richards, W.G. (1992) J. Biomol. Struct. Dyn. 10, 195-211
79. Adlam, G., Blagbrough, IS., Taylor, S., Latham, H.C, Haworth, I.S. and Rodger, A. (1994) Bioorg. Med. Chem. Lett. 4, 2435-2440
80. Rodger, A., Blagbrough, I.S., Adlam, G. and Carpenter, M.L. (1994) Biopolymers 34, 1583-1593
81. Rodger, A., Taylor, S., Adlam, G., Blagbrough, I.S. and Haworth, I.S. (1995) Bioorg. Med. Chem. 3, 861-872
82. Yuki, M., Grukhin, V., Lee, C.S. and Haworth, I.S. (1996) Arch. Biochem. Biophys. 325, 39-46
83. Rodger, A., Sanders, K.J., Hannah, M.J., Meistermann, I., Parkinson, A., Vidler, D.S. and Haworth, I.S. (2000) Chirality 12, 221-236
84. Korolev, N., Lyubartsev, A.P., Laaksonen, A. and Nordenskiold, L. (2002) Biophys. J. 82, 2860-2875
85. Hud, N.V. and Polak, M. (2001) Curr. Opin. Structural Biol. 11, 293-301
86. Egli, M. (2002) Chem. Biol. 9, 277-286
87. Yoshikawa, Y. and Yoshikawa, K. (1995) FEBS Lett. 361, 277-281
88. Blagbrough, I.S., Moya, E. and Taylor, S. (1994) Biochem. Soc. Trans. 22, 888-893
89. Blagbrough, I.S., Taylor, S., Carpenter, M.L., Novoselskiy, V., Shamma, T. and Haworth, I.S. (1998) Chem. Commun. 929-930
90. Carrington, S., Renault, J., Tomasi, S., Sinbandhit, S., Blagbrough, I.S. and Uriac, P. (1999) Pharm. Pharmacol. Commun. 5, 151-157
91. Delcros, J.-G., Tomasi, S., Carrington, S., Martin, B., Renault, J., Blagbrough, I.S. and Uriac, P. (2002) J. Med. Chem. 45, 5098-5111
92. Labat-Moleur, F., Steffan, A.M., Brisson, C., Perron, H., Feugeas, O., Furstenberger, P., Oberling, F., Brambilla, E. and Behr, J.-P. (1996) Gene Therapy 3, 1010-1017
93. Gorman, C.M., Aikawa, M., Fox, B., Fox, E., Lapuz, C., Michaud, B., Nguyen, H., Roche, E., Sawa, T. and WienerKronish, J.P. (1997) Gene Therapy 4, 983-992